Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

aTyr Pharma Inc. (LIFE)

-NasdaqGS
3.27 Down 0.03(0.91%) Sep 26, 4:00PM EDT
Prev Close:3.30
Open:3.27
Bid:N/A
Ask:4.24 x 100
1y Target Est:6.67
Beta:1.41
Earnings Date:Nov 8 - Nov 14 (Est.)
Day's Range:3.15 - 3.33
52wk Range:2.48 - 13.26
Volume:41,640
Avg Vol (3m):224,723
Market Cap:77.56M
P/E (ttm):N/A
EPS (ttm):-2.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.56
Quarterly EPS Est (Sep-16) :-0.67
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback